Zanamivir drug molecule

Zanamivir drug molecule

C026/0453 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 50.0MB

Downloadable file size: 887.0KB

Price image Pricing

Please login to use the price calculator


Caption: Zanamivir. Molecular model of the drug zanamivir (C12.H20.N4.O7), a neuraminidase inhibitor used in the treatment and prevention of infections by the influenza A and B viruses. Its is marketed under the trade name Relenza. Atoms are represented as spheres and are colour-coded: carbon (grey), hydrogen (white), nitrogen (blue) and oxygen (red).

Release details: Model release not required. Property release not required.

Keywords: a and b strains, artwork, biochemistry, black background, chemical, chemistry, cut out, cut outs, cut-out, cut-outs, cutout, cutouts, drug, flu drug, glow, glowing, illustration, influenza, medical, medication, medicine, model, molecular, molecular structure, molecule, neuraminidase inhibitor, no-one, nobody, pharmaceutical, pharmaceutics, pharmacological, pharmacology, relenza, space-fill, space-filled, spacefill, spacefilled, substance, treatment, viral, virus treatment, zanamivir

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.